Growth in cough, cold and allergy (hay fever) remedies in Tunisia is supported by a number of factors. Firstly, Tunisian consumers’ propensity to self-medicate for minor ailments, purchasing OTC products from pharmacists instead of seeking medical attention. Going to see a doctor is expensive in Tunisia and the majority of Tunisians do not have social security cover. In addition, hospitals provide a poor service which has simply worsened due to COVID-19.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table of Contents
Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
List OF CONTENTS AND TABLES
KEY DATA FINDINGS
Category supported by a number of factors, from self-medication trend to high levels of pollution
Declining consumer spending power restricts innovation and trading down is expected
UPSA, Laboratoires maintains lead by advertising on French television and internet channels to overcome Tunisian ad ban
RECOVERY AND OPPORTUNITIES
Ongoing sales driven by seasonal ailments, pollution levels, and COVID-19
Status quo of domestic players producing global brands under license set to continue as provides a win-win scenario
Price-sensitive consumers calling for affordable options
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
COVID-19 impact on consumer health
COVID-19 country impact
What next for consumer health?
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
CONTACT DETAILS :
+44 203 500 2763
+1 62 825 80070